Skip to main content

Tower Research Capital LLC (TRC)

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in TRVI

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$72,679
+$34,873 QoQ
Shares Held
3,897
+23.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#175
of 218 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. TRVI ranks #107 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $72,679 3,897
2026-03-31 $37,806 3,169
2025-12-31 $130,971 10,461
2025-09-30 $25,491 2,786
2025-06-30 $39,373 7,198
2025-03-31 $14,554 2,314
2024-12-31 $10,926 2,652
2024-09-30 $13,036 3,903
2024-06-30 $21,041 7,061
2024-03-31 $2,104 610
2023-12-31 $10,126 7,557
2023-09-30 $14,066 6,453
2023-06-30 $3,589 1,502
2022-09-30 $15,070 9,786
2022-06-30 $10,885 3,874
2022-03-31 $20,849 9,477
2021-12-31 $6,503 8,317
2021-09-30 $6,724 4,803
2021-06-30 $9,420 4,187
2021-03-31 $3,352 1,237
2020-12-31 $12,651 5,228
2020-09-30 $5,670 1,407